Michael P. Stansky is Director at TriSalus Life Sciences, Inc. (TLSI). They have made 3 open-market trades across 2 companies since 2008, most recently 2026-05-15.
CIK 0001424204
3 open-market purchases totalling $5.5M since 2008, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TLSI | 399,698 | $1.5M |
| MAKO | 11,539 | — |
| Total | $1.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-18 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.